Island Pharmaceuticals Limited (ASX:ILA)

Island Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	7.25	1.66	2	4.79	6.46
Cash & Short-Term Investments	7.25	1.66	2	4.79	6.46
Cash Growth	336.76%	-16.91%	-58.26%	-25.90%	646064300.00%
Other Receivables	0.18	0.89	0.02	0.02	0.06
Receivables	0.18	0.89	0.02	0.02	0.06
Prepaid Expenses	0.06	0.01	0.03	0.09	0.12
Total Current Assets	7.49	2.56	2.05	4.9	6.64
Total Assets	7.49	2.56	2.05	4.9	6.64
Accounts Payable	0.15	0.31	0.11	0.24	0.08
Accrued Expenses	0.18	0.3	0.15	0.34	0.14
Short-Term Debt	-	0.42	-	-	-
Other Current Liabilities	0	0.01	0	0	0.01
Total Current Liabilities	0.34	1.05	0.26	0.58	0.24
Total Liabilities	0.34	1.05	0.26	0.58	0.24
Common Stock	31.63	22.39	19.9	19.9	19.83
Retained Earnings	-25.08	-21.2	-19.76	-4.73	-2.13
Comprehensive Income & Other	0.61	0.33	1.65	-10.85	-11.3
Shareholders' Equity	7.16	1.52	1.79	4.32	6.4
Total Liabilities & Equity	7.49	2.56	2.05	4.9	6.64
Total Debt	-	0.42	-	-	-
Net Cash (Debt)	7.25	1.24	2	4.79	6.46
Net Cash Growth	485.58%	-38.03%	-58.26%	-25.90%	646064300.00%
Net Cash Per Share	0.04	0.01	0.02	0.06	0.35
Filing Date Shares Outstanding	247.24	126.77	81.27	81.27	80.97
Total Common Shares Outstanding	236.09	126.77	81.27	81.27	80.97
Working Capital	7.16	1.52	1.79	4.32	6.4
Book Value Per Share	0.03	0.01	0.02	0.05	0.08
Tangible Book Value	7.16	1.52	1.79	4.32	6.4
Tangible Book Value Per Share	0.03	0.01	0.02	0.05	0.08

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.